Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain

被引:51
作者
Kelly, MA
Beuckmann, CT
Williams, SC
Sinton, CM
Motoike, T
Richardson, JA
Hammer, RE
Garry, MG
Yanagisawa, M
机构
[1] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA
[3] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[5] Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA
[6] Japan Sci & Technol Agcy, Explorat Res Adv Technol, Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan
[7] Eisai & Co Ltd, Discovery Res Labs, Tsukuba, Ibaraki 3002635, Japan
关键词
body weight; G protein-coupled receptor 7; neuropeptide W; obesity;
D O I
10.1073/pnas.0503795102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neuropeptide B (NPB) and neuropeptide W (NPW) have been recently identified as ligands for the G protein-coupled receptor (GPR) 7 and GPR8. The precise in vivo role of this neuropeptide-receptor pathway has not been fully demonstrated. In this paper, we report that NPB-deficient mice manifest a mild adult-onset obesity, similar to that reported in GPR7-null mice. NPB-deficient mice also exhibit hyperalgesia in response to inflammatory pain. Hyperalgesia was not observed in response to chemical pain, thermal pain, or electrical stimulation. NPB-deficient mice demonstrated intact behavioral responses to pain, and learning from the negative reinforcement of electrical stimulation was unaltered. Baseline anxiety was also unchanged as measured in both the elevated plus maze and time spent immobile in a novel environment. These data support the idea that NPB is a factor in the modulation of responses to inflammatory pain and body weight homeostasis.
引用
收藏
页码:9942 / 9947
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 2005, Robbins Cotran Pathologic Basis of Disease
[2]   Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release [J].
Baker, JR ;
Cardinal, K ;
Bober, C ;
Taylor, MM ;
Samson, WK .
ENDOCRINOLOGY, 2003, 144 (07) :2816-2821
[3]   Role of growth hormone and prolactin in the control of reproduction: What are we learning from transgenic and knock-out animals? [J].
Bartke, A .
STEROIDS, 1999, 64 (09) :598-604
[4]  
Beuckmann CT, 2003, J NEUROSCI, V23, P6793
[5]   Identification of natural ligands for the orphan G protein-coupled receptors GPR7 and GPR8 [J].
Brezillon, S ;
Lannoy, V ;
Franssen, JD ;
Le Poul, E ;
Dupriez, V ;
Lucchetti, J ;
Detheux, M ;
Parmentier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :776-783
[6]   Post-translationally modified neuropeptides from Conus venoms [J].
Craig, AG ;
Bandyopadhyay, P ;
Olivera, BM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 264 (02) :271-275
[7]   Identification of a neuropeptide modified with bromine as an endogenous ligand for GPR7 [J].
Fujii, R ;
Yoshida, H ;
Fukusumi, S ;
Habata, Y ;
Hosoya, M ;
Kawamata, Y ;
Yano, T ;
Hinuma, S ;
Kitada, C ;
Asami, T ;
Mori, M ;
Fujisawa, Y ;
Fujino, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :34010-34016
[8]  
GYIRES K, 1984, ARCH INT PHARMACOD T, V267, P131
[9]   Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity [J].
Ishii, M ;
Fei, H ;
Friedman, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10540-10545
[10]   Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice [J].
Kelly, MA ;
Rubinstein, M ;
Asa, SL ;
Zhang, G ;
Saez, C ;
Bunzow, JR ;
Allen, RG ;
Hnasko, R ;
BenJonathan, N ;
Grandy, DK ;
Low, MJ .
NEURON, 1997, 19 (01) :103-113